Abbott's MDx Sales Rise 23 Percent in Q2 2010 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott Laboratories today reported 18 percent revenue growth overall for the second quarter ended June 30, and a 23 percent increase in sales of its molecular diagnostic products.

The diagnostics and pharmaceuticals giant reported Q2 sales of $89 million for its molecular diagnostic products, of which $43 million was derived from US sales and the remainder from international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.